Chelsea Therapeutics currently has no approved products. Northera is the lead investigational candidate at the company. We remain concerned about the company’s dependence on Northera for success. A second CRL could be a huge setback for the company. We expect investor focus to stay on the regulatory status of Northera.
Yes, IAG is undervalued, but the POG must keep moving UP.This will help all gold related stocks. Patience is key. Keep dry powder.
If gold stays above the important technical level of $1,530 over the next few weeks then it could go to $1,900 over the next few quarters.
If the Dollar stays strong, gold may not be the save haven we precieve it to be.
Yea,,too low to sell... too high to buy.
J-Man I've been doing some selling also.
This market is making me nervous.
NOT selling any FSC. will buy more latter.
Gold miners HAD boosted production due to higher prices; however, with gold prices seeing a sharp pullback, one can expect miners to cut back production.
GOLD down 5% for FEB.
HL is over 100 years old. A very long term. It has had many ups and downs.This will pay out for those with patience .
That said HL is one of my WORST performing stocks.
But I do love it so. Long term.
The stock is trading at a P/E ratio of 7.36 and a forward P/E ratio of 6.24. The company has a book value of $9.90 per share and the stock has a 3.82% dividend yield. IAG could be a good pick below the book value.Let the fun begin.
Macro Strategies, told CNBC earlier this week that the shift in sentiment towards gold could see the precious metal fall to $1,300 "easily" by the end of the year, a fall of almost 18 percent from current levels.
But LT gold will rebound as currencies take a hit.How low will it go?